Company intelligence / Profile preview

Centarix Biotech

Jerusalem, Jerusalem District, Israelcentarix.com ↗

Ownership: Private
Employees: ~60
Development stage: Commercial

Overview

Centarix has conducted a three-year longitudinal clinical study with hundreds of subjects to develop a comprehensive diagnostic profile for biological aging. Their platform enables precise measurement and tracking of the molecular hallmarks of aging. They operate the advanced "Centa" longevity clinic in Jerusalem, applying these diagnostics and interventions directly to patients. The company is recognized as a global pioneer in longevity science with successful early results from its proprietary technologies.[7][8]

Therapeutic areas: Other
Modalities: Biomarkers/diagnostics (biological age, molecular hallmarks of aging)Epigenetic rejuvenation therapiesGene therapy delivery systems
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Centarix Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centarix Biotech.

Explore the full profile